Anzeige
Mehr »
Login
Mittwoch, 02.12.2020 Börsentäglich über 12.000 News von 647 internationalen Medien
Markanter Ausbruch und massives Aufholpotential in möglicher Jahresendrallye…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0CBDJ ISIN: KYG8167W1380 Ticker-Symbol: SMZ1 
Tradegate
01.12.20
21:48 Uhr
0,760 Euro
-0,065
-7,88 %
Branche
Biotechnologie
Aktienmarkt
HANG SENG
1-Jahres-Chart
SINO BIOPHARMACEUTICAL LTD Chart 1 Jahr
5-Tage-Chart
SINO BIOPHARMACEUTICAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,7400,77001.12.
0,7400,77001.12.

Aktuelle News zur SINO BIOPHARM Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SINO BIOPHARM Aktie jetzt für 0€ handeln
DiSINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "PANTOPRAZOLE SODIUM FOR INJECTION"7
DiSINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME5
DiBrokers' Post-Results TPs, Views on SINO BIOPHARM (01177.HK)4
DiC Suisse Axes SINO BIOPHARM (01177.HK) TP to $9.4; Rated Outperform8
DiNomura cuts Sino Biopharm (01177) to HK$8.976
DiSino Biopharmaceutical shares sink9
DiM Stanley: SINO BIOPHARM (01177.HK) 3Q Recurring Profit Slumps 42% YoY, Misses5
DiSino Biopharm Shares Sink 14% in Hong Kong After Earnings Shock5
MoSino Biopharm (01177) 9-month net down 18% to RMB1,850.5m4
MoSINO BIOPHARM (01177.HK) 1-3Q Net Profit RMB1.85B, Down 18%; QoQ Div HK2 Cents2
MoSINO BIOPHARM (01177): THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER, 20206
18.11.SINO BIOPHARM (01177): NEXT DAY DISCLOSURE RETURN11
13.11.Sino Biopharm (01177) gets drug registration certificate11
13.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - "POMALIDOMIDE CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE5
12.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - LATEST INFORMATION REGARDING THE STUDY OF PENPULIMAB FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSIC HODGKIN LYMPHOMA PRESENTED AT SITC 20204
12.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - LATEST INFORMATION REGARDING THE STUDY OF PENPULIMAB FOR TREATMENT OF PATIENTS WITH METASTATIC NASOPHARYNGEAL CARCINOMA WHO HAD PROGRESSED AFTER TWO OR ...3
09.11.SINO BIOPHARM (01177): UPDATE ON DIRECTOR'S INFORMATION PURSUANT TO RULE 13.51B(2) AND RULE 13.51(2)(L) OF THE LISTING RULES4
05.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "BORTEZOMIB FOR INJECTION"1
05.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "ESOMEPRAZOLE SODIUM FOR INJECTION"2
04.11.SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION"2
Seite:  Weiter >>
103 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2